lme4qtl
lme4qtl extends lme4 to enable quantitative trait locus (QTL) mapping by fitting linear mixed models (LMMs) for related individuals using custom covariance structures.
Key Features:
- Custom Covariance Matrices: Allows random effects to be defined using user-specified covariance matrices, including multiple covariance matrices to model complex levels of relatedness.
- Parameter Constraints: Implements parameter constraints to enforce biologically meaningful limits during model estimation.
- Integration with lme4: Integrates with the lme4 framework and its companion packages to leverage established LMM functionality.
- Efficiency in Sparse Covariance Scenarios: Optimizes computations for sparse covariance matrices to improve performance in large family-structured genetic studies.
Scientific Applications:
- Linkage Analysis: Supports linkage studies by modeling relatedness among individuals within LMMs.
- Association Studies and GWAS: Enables association analyses and genome-wide association study (GWAS) scenarios that require modeling of various relatedness levels.
- Family-based QTL Mapping (GAIT2): Applied to family-based datasets such as the Genetic Analysis of Idiopathic Thrombophilia 2 (GAIT2) project to demonstrate practical utility.
Methodology:
Fits linear mixed models via lme4, supports custom and multiple covariance matrices for random effects, enforces parameter constraints, and applies computational optimizations for sparse covariance matrices.
Topics
Details
- License:
- GPL-3.0
- Tool Type:
- library
- Operating Systems:
- Linux, Windows, Mac
- Programming Languages:
- R
- Added:
- 7/29/2018
- Last Updated:
- 12/10/2018
Operations
Publications
Ziyatdinov A, Vázquez-Santiago M, Brunel H, Martinez-Perez A, Aschard H, Soria JM. lme4qtl: linear mixed models with flexible covariance structure for genetic studies of related individuals. BMC Bioinformatics. 2018;19(1). doi:10.1186/s12859-018-2057-x. PMID:29486711. PMCID:PMC5830078.
PMID: 29486711
PMCID: PMC5830078
Funding: - Instituto de Salud Carlos III Fondo de Investigación Sanitaria: PI 14/0582
- National Institutes of Health: R21HG007687